# Kaempferol Mitigates CSE‐Induced Lung Injury and Epithelial Cell Ferroptosis via Modulating Nrf2/NCOA4/GPx4 Axis

**Authors:** Fengri Jin, Yanfei Xing, Songyu Li, Zhennan Yi, Aibin Wu, Xin Li

PMC · DOI: 10.1111/jcmm.71010 · Journal of Cellular and Molecular Medicine · 2025-12-31

## TL;DR

Kaempferol helps protect lung cells from cigarette smoke damage by preventing a type of cell death called ferroptosis through a specific molecular pathway.

## Contribution

Kaempferol's anti-ferroptotic mechanism via the Nrf2/NCOA4/GPx4 axis in CSE-induced lung injury is newly elucidated.

## Key findings

- Kaempferol restored cell viability and redox balance by increasing GSH and reducing MDA and Fe2+ levels.
- KF inhibited ferritinophagy through NCOA4 suppression and rescued GPx4 activity to block lipid peroxidation.
- Nrf2-dependent transcriptional activation mediated KF's protective effects against CSE-induced ferroptosis.

## Abstract

Ferroptosis, an iron‐dependent regulated necrosis driven by redox imbalance, plays a critical role in the pathogenesis of chronic obstructive pulmonary disease (COPD). Kaempferol (KF), a bioactive flavonoid from Polygonati Rhizoma, exhibits anti‐ferroptotic properties in lipid peroxidation disorders, yet its molecular mechanism against cigarette smoke extract (CSE)‐induced ferroptosis in human bronchial epithelial cells (BEAS‐2B) remains to be fully elucidated. Using in vitro models of CSE‐induced injury, we observed that KF restored cell viability and attenuated cytotoxicity by restoring redox equilibrium—significantly elevating glutathione (GSH) while reducing malondialdehyde (MDA) and labile iron pool (Fe2+) levels. Mechanistically, KF suppressed ferritinophagy via nuclear receptor coactivator 4 (NCOA4) inhibition and rescued glutathione peroxidase 4 (GPx4) activity, thereby blocking lipid peroxidation cascades. These effects were mediated through Nrf2‐dependent transcriptional activation, counteracting CSE‐triggered Nrf2 pathway dysregulation. Our findings reveal that KF mitigates COPD progression by coordinately targeting the Nrf2/NCOA4/GPx4 axis to inhibit ferroptosis, providing a novel therapeutic strategy for oxidative stress‐driven pulmonary diseases.

## Linked entities

- **Genes:** GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], NCOA4 (nuclear receptor coactivator 4) [NCBI Gene 8031], GPX4 (glutathione peroxidase 4) [NCBI Gene 2879]
- **Chemicals:** Kaempferol (PubChem CID 5280863), glutathione (PubChem CID 124886), malondialdehyde (PubChem CID 10964)
- **Diseases:** chronic obstructive pulmonary disease (MONDO:0005002), COPD (MONDO:0005002)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, NCOA4 (nuclear receptor coactivator 4) [NCBI Gene 8031] {aka ARA70, ELE1, PTC3, RFG}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}
- **Diseases:** pulmonary diseases (MESH:D008171), cytotoxicity (MESH:D064420), Lung Injury (MESH:D055370), necrosis (MESH:D009336), lipid peroxidation disorders (MESH:D011017), COPD (MESH:D029424)
- **Chemicals:** KF (MESH:C006552), CSE (-), GSH (MESH:D005978), flavonoid (MESH:D005419), iron (MESH:D007501), MDA (MESH:D008315), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12755056/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12755056/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12755056/full.md

---
Source: https://tomesphere.com/paper/PMC12755056